Experienced Oncology Drug Developer and Neuro-Oncologist will Lead Tocagen's Registrational Toca 5 Study Previously Led Activities Surrounding Approval and Launch of Avastin® for Glioblastoma SAN ...
Asha Das's most active month to dispose stocks was the month of May. 2017 saw Asha Das paying a total of $46,250.00 for 142,246 shares, this is the most they've acquired in one year. In 2020 Asha Das ...
Tocagen has named Lori Kunkel, M.D., as its acting chief medical officer following the departure of Asha Das, M.D., who is leaving because of “unforeseen and immediate personal matters.” Kunkel—who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results